Jaroslav Kralovec, PhD
VP CHEMISTRY
Dr. Jaroslav Kralovec was a Senior Director of R&D at DSM for 8 years through the acquisition of Ocean Nutrition for $500M where he was a founding member. Dr. Kralovec played leading roles in the development of the omega-3 products Lovaza and Vascepa and in novel process development for Epanova, starting in the lab in 2006. Epanova was later bought by AstraZeneca for $443 M.
